Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Farmakologiia I Toksikologiia
|
May 1, 1990
[The anti-arrhythmia properties of bonnecor metabolites]
E K Grigor'eva, H Poppe, E A Tolmacheva, et al.
Die Pharmazie
|
January 1, 1989
[Synthesis of 3-cyano-6-methyl-4-pyridyl-2(1H)-pyridinethiones as well as 2-substituted 6-methyl-4-pyridyl-pyridine-3-carbonitriles and 3-carbonic acid amides, respectively, and testing their cardiovascular activity]
V Hanfeld, S Leistner, G Wagner, et al.
Die Pharmazie
|
October 1, 1988
[Synthesis of 3-substituted 6-methyl-4-pyridyl-2 (1H) pyridones and testing of their cardiovascular action]
V Hanfeld, S Leistner, G Wagner, et al.
Biomedical Chromatography : BMC
|
July 1, 1998
Effect of the particle size in capillary electrochromatography
R M Seifar, S Heemstra, W T Kok, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
July 16, 2003
Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways
I Szelenyi, G Hochhaus, S Heer, et al.
Farmakologiia I Toksikologiia
|
May 1, 1990
[The relationship between the physicochemical and pharmacokinetic parameters and the anti-arrhythmia activity of bonnecor and its metabolites]
A P Rodionov, N N Zolotov, V V Lyskovtsev, et al.
Journal of Chromatography. A
|
August 15, 1997
Comparison of five methods for the study of drug-protein binding in affinity capillary electrophoresis
M H Busch, L B Carels, H F Boelens, et al.
Cardiovascular Drugs and Therapy
|
November 1, 1996
Effects of AWD 23-111, a new antiarrhythmic substance, on cardiac conduction and refractoriness
U Stark, G Stark, I Schwarzl, et al.
Journal of Chromatography. A
|
September 13, 1996
Critical evaluation of the applicability of capillary zone electrophoresis for the study of hapten-antibody complex formation
M H Busch, H F Boelens, J C Kraak, et al.
Die Pharmazie
|
December 1, 1985
[Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat]
H Poppe, K Femmer, N V Kaverina, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Farmakologiia I Toksikologiia
|
May 1, 1990
[The anti-arrhythmia properties of bonnecor metabolites]
E K Grigor'eva, H Poppe, E A Tolmacheva, et al.
Die Pharmazie
|
January 1, 1989
[Synthesis of 3-cyano-6-methyl-4-pyridyl-2(1H)-pyridinethiones as well as 2-substituted 6-methyl-4-pyridyl-pyridine-3-carbonitriles and 3-carbonic acid amides, respectively, and testing their cardiovascular activity]
V Hanfeld, S Leistner, G Wagner, et al.
Die Pharmazie
|
October 1, 1988
[Synthesis of 3-substituted 6-methyl-4-pyridyl-2 (1H) pyridones and testing of their cardiovascular action]
V Hanfeld, S Leistner, G Wagner, et al.
Biomedical Chromatography : BMC
|
July 1, 1998
Effect of the particle size in capillary electrochromatography
R M Seifar, S Heemstra, W T Kok, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
July 16, 2003
Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways
I Szelenyi, G Hochhaus, S Heer, et al.
Farmakologiia I Toksikologiia
|
May 1, 1990
[The relationship between the physicochemical and pharmacokinetic parameters and the anti-arrhythmia activity of bonnecor and its metabolites]
A P Rodionov, N N Zolotov, V V Lyskovtsev, et al.
Journal of Chromatography. A
|
August 15, 1997
Comparison of five methods for the study of drug-protein binding in affinity capillary electrophoresis
M H Busch, L B Carels, H F Boelens, et al.
Cardiovascular Drugs and Therapy
|
November 1, 1996
Effects of AWD 23-111, a new antiarrhythmic substance, on cardiac conduction and refractoriness
U Stark, G Stark, I Schwarzl, et al.
Journal of Chromatography. A
|
September 13, 1996
Critical evaluation of the applicability of capillary zone electrophoresis for the study of hapten-antibody complex formation
M H Busch, H F Boelens, J C Kraak, et al.
Die Pharmazie
|
December 1, 1985
[Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat]
H Poppe, K Femmer, N V Kaverina, et al.
Page
of 9